Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

Aim. To determine the value of polymorphisms of the immune response genes for the treatment efficacy in MM patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation (autoHSCT). Methods. The overall of 20 ММ patients (8 men and 12 women) were included in the...

Full description

Bibliographic Details
Main Authors: EL Nazarova, NV Minaeva, MN Khorobrykh, EE Sukhorukova, VI Shardakov, IV Paramonov, NA Zorina
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2018-01-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
multiple myeloma
gene polymorphisms
immune response
cytokine
Toll-like receptor
high-dose chemotherapy
autologous hematopoietic stem cell transplantation
Online Access:http://bloodjournal.ru/wp-content/uploads/2018/01/7.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2018/01/7.pdf

Similar Items